Table 1

Primary objective and outcome measure

Primary objectiveOutcome measureTime point of outcome measured
To evaluate the difference in rates of diagnosis and cure of HCV in patients receiving OST between the pharmacy-intervention and education-only pathways.Proportion of patients in a population of stable OST clients achieving SVR12 in the pharmacy-intervention pathway versus education-only pathway (Intention to Treat).At least 12 weeks after participants finish their HCV treatment.
  • HCV, hepatitis C virus; OST, opiate substitution therapy; SVR12, sustained viral response at 12 weeks.